Autopsy findings in COVID-19-related deaths: a literature review

Abstract

Although many clinical reports have been published, little is known about the pathological post-mortem findings from people who have died of the novel coronavirus disease. The need for postmortem information is urgent to improve patient management of mild and severe illness, and treatment strategies. The present systematic review was carried out according to the Preferred Reporting Items for Systematic Review (PRISMA) standards. A systematic literature search and a critical review of the collected studies were conducted. An electronic search of PubMed, Science Direct Scopus, Google Scholar, and Excerpta Medica Database (EMBASE) from database inception to June 2020 was performed. We found 28 scientific papers; the total amount of cases is 341. The major histological feature in the lung is diffuse alveolar damage with hyaline membrane formation, alongside microthrombi in small pulmonary vessels. It appears that there is a high incidence of deep vein thrombosis and pulmonary embolism among COVID-19 decedents, suggesting endothelial involvement, but more studies are needed. A uniform COVID-19 post-mortem diagnostic protocol has not yet been developed. In a time in which international collaboration is essential, standardized diagnostic criteria are fundamental requirements.

The Many Faces of Covid-19 at a Glance: A University Hospital Multidisciplinary Account From Milan, Italy

“…We found the virus in the olfactory system and in the medulla oblongata ( 26 ). A review of 28 papers by Maiese et al on a total of 341 cases showed alveolar damage with hyaline membrane formation and microthrombi in pulmonary vessels ( 43 ). In a recent autopsy study by Schurink et al in SARS-CoV-2, multiple organs had infected cells, especially in the lungs, but during the disease course these decreased ( 44 ).…”

COVID-19 Risk Management and Screening in the Penitentiary Facilities of the Salerno Province in Southern Italy

“…An infected person may exhibit symptoms after an incubation period that can range from about 2 to 14 days (there have been cases up to 29 days). During this time, the infected person is contagious [2,3]. The virus is transmitted through air, in particular through respiratory droplets [4].…”

Corticosteroids for COVID-19: the search for an optimum duration of therapy

“…In autopsy studies of patients with COVID-19, diffuse alveolar disruption with large vessel thrombi and microthrombi were seen. 4 Dexamethasone (6 mg per day) tends to increase clotting factor and fibrinogen concentrations. Thus, it is plausible for exogenous glucocorticoids to precipitate clinical thrombosis.…”